CCRM
Toronto, ON, Canada
National Center
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
78.1
Signal Score
✓ FDA Inspections (5)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: CCRM
- Signal Score
- 78.1/100 (as of 2026-09-07)
- Quality Compliance
- 100.0/100
- Headquarters
- Toronto, ON, Canada
- Modalities
- Cell Therapy, mRNA
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About CCRM
CDMO.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
100.0
FDA Inspections5 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-09-04)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, mRNA
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
58.0
Profile-based capacity assessment
CCRM FDA Inspection History
2025-09
2025-08
2025-07
2025-03
2025-03
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-09-04 |
CCRM DFW
Frisco, Texas
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2025-08-21 |
CCRM Boston
Chestnut Hill, Massachusetts
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2025-07-22 |
CCRM Minneapolis
Edina, Minnesota
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2025-03-27 |
CCRM San Francisco, LLC
Menlo Park, California
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2025-03-21 |
CCRM New York
New York, New York
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 07, 2026
Frequently Asked Questions About CCRM
How many FDA inspections does CCRM have on record?
CDMO Signal tracks 5 FDA inspections for CCRM, sourced from the FDA inspection database. See the full inspection history above.
Has CCRM received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for CCRM.
What is CCRM's CDMO Signal Score?
CCRM has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating CCRM for a manufacturing program?
Use the free AI matchmaker to compare CCRM against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Danaher (CGT Portfolio)
Washington, DC
Signal Score: 81.5
Cell Therapy, AAV, mRNA
Lonza
Basel, Switzerland
Signal Score: 76.0
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Signal Score: 74.5
mRNA, Gene Therapy, Cell Therapy, Lentiviral
Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
Signal Score: 74.0
Cell Therapy, AAV, mRNA